Generate Biomedicines(GENB)

Challenger

Generative biology biotech using AI to design protein therapeutics. IPO'd on Nasdaq (GENB) Feb 2026, raising $400M. Lead drug GB-0895 in Phase 3 for severe asthma.

AI Drug Discovery & Generative Biology
GENB
Visit Website
Updated April 2026

Company Overview

About Generate Biomedicines

Generate Biomedicines is a clinical-stage biotech founded in 2018 by Flagship Pioneering, headquartered in Somerville, Massachusetts. The company pioneers generative biology, using ML and large-scale experimental systems to design protein therapeutics. Its platform combines diffusion and graph-based AI models with high-throughput biohardware. The pipeline spans immunology, oncology, and infectious diseases.

Business Model & Competitive Advantage

Generate's model combines internal drug development with collaboration revenue from Amgen and Novartis. Lead program GB-0895, a long-acting anti-TSLP antibody engineered for every-six-month dosing, is in Phase 3 for severe asthma with FDA Fast Track designation (January 2026). It competes with Recursion Pharmaceuticals and Absci.

Competitive Landscape 2025–2026

Generate went public on Nasdaq in February 2026 under ticker GENB, raising approximately $400 million. 2025 collaboration revenue was $31.89 million against a $222.97 million net loss. With 312 employees, the company is advancing its Phase 3 program and expanding its generative biology platform.

Revenue
$400M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Strong Challenger

Generate Biomedicines is an established challenger with significant market presence and competitive offerings in Healthcare Tech.

Growth Stage

Generate Biomedicines has achieved $400M in revenue, demonstrating strong product-market fit.

Frequently Asked Questions

Compare Generate Biomedicines with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

Start Comparison →
For Generate Biomedicines

Claim This Profile

Are you from Generate Biomedicines? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Generate Biomedicines Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Generate Biomedicines vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →